Results 61 to 70 of about 16,243 (160)
ABSTRACT Background From late 2022, there was an increase in cases of invasive group A streptococcus (iGAS) reported in the Northern Hemisphere and there was a similar increase noted in the referrals to the Newborn and Paediatric Emergency Transport service (NETS NSW), in the state of New South Wales (NSW), Australia.
Laura Scerri+4 more
wiley +1 more source
Juvenile Dermatomyositis Triggered by Influenza B: A Case Report on Viral‐Induced Autoimmunity
ABSTRACT A previously healthy 13‐year‐old boy developed juvenile dermatomyositis (JDM) shortly after a confirmed influenza B infection, presenting with progressive proximal muscle weakness and classic cutaneous findings. Laboratory tests revealed elevated muscle enzymes and myositis‐specific autoantibodies, supporting the diagnosis.
Santiago Dans‐Caballero+4 more
wiley +1 more source
The use of cough/nasal swabs in the rapid diagnosis of respiratory syncytial virus infection by the fluorescent antibody technique [PDF]
J. McQuillin+2 more
openalex +1 more source
Limited data on syndromic panels for detecting respiratory tract infections in lung transplant candidates and recipients are available. While these panels provide a rapid turnaround time, they may fail to identify specific pathogens relevant in this setting, such as fungi.
Andrea Lombardi+4 more
wiley +1 more source
PATTERNS OF HYPOXEMIA IN INFANTS WITH RESPIRATORY SYNCYTIAL VIRUS(RSV) BRONCHIOLITIS AND PNEUMONIA, MEASURED BY EAR OXIMETRY [PDF]
Caroline Breese Hall+3 more
openalex +1 more source
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon+4 more
wiley +1 more source
Altered reactivity to respiratory syncytial virus: Antibody response to RSV antigens and studies of the pathogensis of atypical RSV illness in recipients of inactivated vaccine [PDF]
Jerry J. Eller+5 more
openalex +1 more source
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy
ABSTRACT Vaccine adjuvants are essential for enhancing immune responses to vaccines, particularly in immunocompromised populations who typically demonstrate suboptimal responses to standard vaccination. This narrative review evaluates the safety and efficacy of approved and candidate adjuvants in immunocompromised hosts, with emphasis on solid organ ...
Haya Hayek+8 more
wiley +1 more source
Abstract Background The coronavirus disease‐19 (COVID‐19) pandemic has affected global health, influencing the prevalence of different respiratory pathogens. The aim of this study is to evaluate the distribution of agents causing acute respiratory infections in children under 5 years old before and after the COVID‐19 pandemic in Praia, Cabo Verde, and ...
Wilson Correia+5 more
wiley +1 more source